FDA.reportPublic FDA data

METHACRYLIC ACID

Substance profile for UNII 1CS02G8656, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for METHACRYLIC ACID
Structure render from PubChem CID 4093

Substance Identity#

UNII
1CS02G8656
Preferred term
METHACRYLIC ACID
Registry number
79-41-4
EC number
201-204-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C4H6O2
Chemical structure for METHACRYLIC ACID
Structure render from PubChem CID 4093

Chemical And Database Identifiers#

InChIKey
CERQOIWHTDAKMF-UHFFFAOYSA-N
SMILES
CC(=C)C(O)=O
RxCUI
1424905
PubChem
4093
NCIt
C61838
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4093https://pubchem.ncbi.nlm.nih.gov/compound/4093
PubChem InChIKey SearchCERQOIWHTDAKMF-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=CERQOIWHTDAKMF-UHFFFAOYSA-N
RxNorm1424905https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1424905
NCI ThesaurusC61838https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C61838
FDA Substance Registration System1CS02G8656https://precision.fda.gov/uniisearch/srs/unii/1CS02G8656
European Community number201-204-4https://commonchemistry.cas.org/results?q=201-204-4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LANSOPRAZOLE7
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656ESOMEPRAZOLE MAGNESIUM1
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656Solmara1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656MEDPURINE3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use oxybutynin chloride extended-release tablets safely and effectively. See full prescribing information for oxybutynin chloride extended-release tablets. Oxybutynin Chloride Extended-Release Tablets for oral use Initial U.S. Approval: 19751001
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use pantoprazole sodium delayed-release tablets safely and effectively. See full prescribing information for pantoprazole sodium delayed-release tablets. PANTOPRAZOLE sodium delayed-release tablets, USP, for oral use Initial U.S. Approval: 20001
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 19831
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OXYBUTYNIN CHLORIDE EXTENDED RELEASE TABLETS, 5 MG, 10 MG AND 15 MG1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN 81mg1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Initial U.S. Approval: 19971
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use divalproex sodium delayed-release tablets, USP safely and effectively. See full prescribing information for divalproex sodium delayed-release tablets, USP . D ivalproex Sodium Delayed-Release Tablets, USP for Oral Use Initial U.S. Approval: 19831
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-release Capsules, USP INITIAL U.S. APPROVAL: 19891
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G865695c34d67-3a72-49d4-89aa-7186ac58c0dc2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656b3180408-a3c0-4e02-8535-dea390a522777
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Drug Facts1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Drug Facts1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Drug Facts1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use didanosine delayed-release capsules safely and effectively. See full prescribing information for didanosine delayed-release capsules. Initial U.S. Approval: 19911
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19893
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DICLOFENAC SOD DR4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTOCORT® EC (budesonide) CAPSULES2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use VIMOVO safely and effectively. See full prescribing information for VIMOVO. VIMOVO ® (naproxen and esomeprazole magnesium) DELAYED RELEASE TABLETS Initial U.S. Approval: April 20101
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Aspirin Drug Facts1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DRUG FACTS1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Aspirin Tablets1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656Drug Facts2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial U.S. Approval: 19912
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use tamsulosin hydrochloride capsules safely and effectively. See full prescribing information for tamsulosin hydrochloride capsules. Initial U.S. Approval: 19971
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION Initial U.S. Approval: 1989 (omeprazole)1
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use omeprazole delayed-release capsules safely and effectively. See full prescribing information for omeprazole delayed-release capsules. Omeprazole Delayed-Release Capsules, USP Initial U.S. Approval: 19891
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3473
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1001
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [BRYANT RANCH PREPACK]1000
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]1000
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]41
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656PRILOSEC (OMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE PRILOSEC (OMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [ASTRAZENECA LP]29
methacrylic acidINACTIVE INGREDIENT1CS02G8656PREVACID (LANSOPRAZOLE) CAPSULE, DELAYED RELEASE PREVACID SOLUTAB (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [TAKEDA PHARMACEUTICALS AMERICA, INC.]28
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LAMICTAL XR (LAMOTRIGINE) TABLET, FILM COATED, EXTENDED RELEASE LAMICTAL XR (LAMOTRIGINE) KIT [GLAXOSMITHKLINE LLC]25
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM DELAYED-RELEASE (DIVALPROEX SODIUM) TABLET, FILM COATED [QUALITEST PHARMACEUTICALS]21
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656VIMOVO (NAPROXEN AND ESOMEPRAZOLE MAGNESIUM) TABLET, DELAYED RELEASE [ASTRAZENECA LP]15
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM TABLET, DELAYED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]13
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM CAPSULE, COATED PELLETS [ZYDUS PHARMACEUTICALS (USA) INC.]12
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ESOMEPRAZOLE STRONTIUM CAPSULE, DELAYED RELEASE [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC]12
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]12
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]11
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [ACTAVIS SOUTH ATLANTIC LLC]10
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM TABLET, DELAYED RELEASE [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]10
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [SAFEWAY]8
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656KETOPROFEN CAPSULE KETOPROFEN CAPSULE, EXTENDED RELEASE [MYLAN PHARMACEUTICALS INC.]8
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [ACTAVIS INC.]8
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656TAMSULOSIN HYDROCHLORIDE CAPSULE [ZYDUS PHARMACEUTICALS (USA) INC.]8
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUDESONIDE CAPSULE [PAR PHARMACEUTICAL INC.]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [ACTAVIS PHARMA, INC.]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION TABLET, EXTENDED RELEASE [ZYDUS PHARMACEUTICALS (USA) INC.]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DICLOFENAC SODIUM TABLET, DELAYED RELEASE [MYLAN PHARMACEUTICALS INC.]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTERIC COATED ASPIRIN (ASPIRIN) TABLET [FAMILY DOLLAR]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTERIC COATED ASPIRIN (ASPIRIN) TABLET [NASH-FINCH COMPANY]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ESOMEPRAZOLE STRONTIUM CAPSULE, DELAYED RELEASE [AMNEAL PHARMACEUTICALS, LLC]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LAMOTRIGINE EXTENDED RELEASE TABLET [PAR PHARMACEUTICAL INC.]7
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTOCORT EC (BUDESONIDE) CAPSULE [PROMETHEUS LABORATORIES INC]6
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE [DR. REDDY'S LABORATORIES LIMITED]6
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OMEPRAZOLE CAPSULE, DELAYED RELEASE [CARDINAL HEALTH]6
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OMEPRAZOLE CAPSULE, DELAYED RELEASE [MYLAN INSTITUTIONAL INC.]6
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OXYBUTYNIN CHLORIDE TABLET, EXTENDED RELEASE [TEVA PHARMACEUTICALS USA INC]6
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN ENTERIC COATED (ASPIRIN) TABLET, DELAYED RELEASE [CHAIN DRUG MARKETING ASSOCIATION INC]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN TABLET, COATED [KEM PHARMA LLC]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN TABLET, COATED [L&R DISTRIBUTORS, INC.]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTERIC COATED LOW DOSE ASPIRIN (ASPIRIN) TABLET, COATED [WALGREEN CO.]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ENTOCORT EC (BUDESONIDE) CAPSULE [ASTRAZENECA LP]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LOW DOSE ASPIRIN (ASPIRIN) TABLET [SUPERVALU INC.]5
methacrylic acidINACTIVE INGREDIENT1CS02G8656PREVACID (LANSOPRAZOLE) TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE [CARDINAL HEALTH]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656VIMOVO (NAPROXEN AND ESOMEPRAZOLE MAGNESIUM) TABLET, DELAYED RELEASE [HORIZON PHARMA INC.]5
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN ADULT LOW DOSE (ASPIRIN) TABLET, COATED [GREAT LAKES WHOLESALE, MARKETING, & SALES, INC.]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN ENTERIC COATED (ASPIRIN) TABLET, COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [BETTER LIVING BRANDS, LLC]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [SAVE-A-LOT FOOD STORES, LTD.]4
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656ASPIRIN TABLET, COATED [NEW WORLD IMPORTS, INC]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656COATED ASPIRIN LOW-DOSE (ASPIRIN) TABLET, COATED [TARGET CORPORATION]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DICLOFENAC SODIUM TABLET, DELAYED RELEASE [PREFERRED PHARMACEUTICALS, INC.]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LOW DOSE ASPIRIN (ASPIRIN) TABLET [WAL-MART STORES INC]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656NEXIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE NEXIUM (ESOMEPRAZOLE MAGNESIUM) GRANULE, DELAYED RELEASE [CARDINAL HEALTH]4
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656NICOTINE TRANSDERMAL SYSTEM (NICOTINE ) KIT [DR. REDDY'S LABORATORIES LIMITED]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656TAMSULOSIN HYDROCHLORIDE CAPSULE [BRYANT RANCH PREPACK]4
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN ENTERIC COATED LOW DOSE (ASPIRIN) TABLET, COATED [WALGREEN CO.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET [SUPERVALU INC.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [FRED'S, INC.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [L&R DISTRIBUTORS, INC.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW STRENGTH (ASPIRIN) TABLET, COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DICLOFENAC SODIUM TABLET, DELAYED RELEASE [MYLAN INSTITUTIONAL INC.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM CAPSULE, COATED PELLETS [AMERICAN HEALTH PACKAGING]3
Methacrylic AcidINACTIVE INGREDIENT1CS02G8656NICOTINE TRANSDERMAL SYSTEM STEP 1 (NICOTINE) PATCH, EXTENDED RELEASE NICOTINE TRANSDERMAL SYSTEM STEP 2 (NICOTINE) PATCH, EXTENDED RELEASE NICOTINE TRANSDERMAL SYSTEM STEP 3 (NICOTINE) PATCH, EXTENDED RELEASE [DR. REDDY'S LABORATORIES INC.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656OMEPRAZOLE CAPSULE, DELAYED RELEASE [BRYANT RANCH PREPACK]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656PAIN RELIEF ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [RITE AID]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656PANTOPRAZOLE SODIUM TABLET, DELAYED RELEASE [PROFICIENT RX LP]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656SIMPEX BISACODYL LAXATIVE (BISACODYL) TABLET, COATED [SIMPEX PHARMA PVT. LTD]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656TAMSULOSIN HYDROCHLORIDE CAPSULE [AMERICAN HEALTH PACKAGING]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656TAMSULOSIN HYDROCHLORIDE CAPSULE [CADILA HEALTHCARE LIMITED]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656WOMENS LAXATIVE (BISACODYL) TABLET, COATED [WALGREEN CO.]3
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN 81 MG NSAID LOW DOSE (ASPIRIN) TABLET, COATED [DOLGENCORP, LLC]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN ADULT LOW DOSE (ASPIRIN) TABLET, COATED [WAL-MART STORES INC]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [ARMY AND AIR FORCE EXCHANGE SERVICE]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW DOSE (ASPIRIN) TABLET, COATED [CHAIN DRUG CONSORTIUM]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN LOW STRENGTH ADULT (ASPIRIN) TABLET, COATED [SAM'S WEST INC]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN TABLET [ADVANCE PHARMACEUTICAL INC.]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ASPIRIN TABLET [ADVANCE PHARMACEUTICAL INC.]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION HYDROCHLORIDE TABLET, EXTENDED RELEASE [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656BUPROPION TABLET, EXTENDED RELEASE [CADILA HEALTHCARE LIMITED]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656C-LAX LAXATIVE (BISACODYL) TABLET, COATED [WOONSOCKET PRESCRIPTION CENTER,INCORPORATED]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656DIVALPROEX SODIUM TABLET, DELAYED RELEASE [CADILA HEALTHCARE LIMITED]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM) CAPSULE, DELAYED RELEASE [CAMBER PHARMACEUTICALS, INC.]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656HEALTHMART NICOTINE TRANSDERMAL SYSTEM STEP 1 (NICOTINE) PATCH, EXTENDED RELEASE HEALTHMART NICOTINE TRANSDERMAL SYSTEM STEP 2 (NICOTINE) PATCH, EXTENDED RELEASE HEALTHMART NICOTINE TRANSDERMAL SYSTEM STEP 3 (NICOTINE) PATCH, EXTENDED RELEASE [MCKESSON]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656KROGER NICOTINE TRANSDERMAL SYSTEM STEP 1 (NICOTINE) PATCH, EXTENDED RELEASE KROGER NICOTINE TRANSDERMAL SYSTEM STEP 2 (NICOTINE) PATCH, EXTENDED RELEASE KROGER NICOTINE TRANSDERMAL SYSTEM STEP 3 (NICOTINE) PATCH, EXTENDED RELEASE [NOVARTIS CONSUMER HEALTH]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LANSOPRAZOLE CAPSULE, DELAYED RELEASE PELLETS [ZYDUS PHARMACEUTICALS (USA) INC.]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LAXATIVE WOMEN (BISACODYL) TABLET, COATED [WINCO FOODS, LLC]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656LOW DOSE ASPIRIN 81 MG SAFETY COATED (ASPIRIN) TABLET, DELAYED RELEASE [FAMILY DOLLAR (FAMILY WELLNESS)]2
METHACRYLIC ACIDINACTIVE INGREDIENT1CS02G8656MEIJER NICOTINE TRANSDERMAL SYSTEM STEP 2 (NICOTINE) PATCH, EXTENDED RELEASE [NOVARTIS CONSUMER HEALTH]2